№ files_lp_4_process_2_90133
File format: docx
Character count: 6128
File size: 33 KB
Official municipal job description outlining duties, responsibilities, employment conditions, and compliance requirements for a Vaccine Tracing Officer position supporting the COVID-19 vaccination programme within Broxbourne Borough Council.
Job title:
Vaccine Tracing Officer
Date compiled / amended:
December 2021
Department:
Environmental Health
Compiled by:
RB/LA
Organisation:
Broxbourne Borough Council
Region / city:
Broxbourne
Country:
United Kingdom
Document type:
Job description
Subject:
COVID-19 vaccination outreach and community engagement
Programme:
COVID-19 vaccine roll out programme
Reporting to:
Environmental Health Manager
Professional supervision:
Environmental Health Team Leader and Covid Response Manager
Work location:
Borough Offices
Working hours:
37 hours per week
Grade:
I 37
Equipment:
Computers, personal protective equipment
Systems used:
Microsoft Dynamics, spreadsheets
Key partners:
Broxbourne Healthcare Providers, GP surgery staff
Target groups:
Community groups and residents within the borough
Main duties:
Community engagement, vaccine confidence building, resident contact, administrative data management
Legal framework referenced:
Asylum and Immigration Act 1996; Rehabilitation of Offenders Act 1974
Employment checks:
Right to work verification, National Insurance confirmation, criminal record disclosure where applicable
Policy areas:
Equal opportunities, safeguarding, employment of ex-offenders
Language requirement:
Accurate spoken English for public communication
Alcohol restriction status:
Yes
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Year:
2023
Region / City:
Tucson, Arizona
Topic:
African American Disability Awareness, Trauma
Document Type:
Conference Transcript
Organization:
Arizona Center for Disability Law
Author:
Natalie Luna Rose, Dr. Carlian Dawson, Ruben Gallego
Target Audience:
Disability advocates, African American communities, researchers on trauma
Period of Validity:
June 2023 (in-person event)
Approval Date:
February 9, 2023
Modification Date:
Not specified
Conference Date:
June 16, 2023
Supporting Organizations:
Arizona Center for African American Resources, Arizona Department of Health Services, UnitedHealthcare, Arizona Community Foundation, and others
Accessibility:
CART captioning, ASL interpretation
Context:
Transcript from a virtual preview session for the African American Conference on Disabilities discussing historical trauma and its modern-day effects, presented by experts in the field.
Year:
2023
Region / City:
N/A
Subject:
Integration Flow Tracing
Document Type:
Technical Guide
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Integration Developers, Tenant Administrators
Period of validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Log Level:
Debug
Trace Duration:
10 minutes
Year:
2026
Region / city:
Global
Topic:
Social protection, fragile states
Document type:
Research paper
Institution:
World Bank
Author:
Not specified
Target audience:
Researchers, policymakers, development professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Keywords:
social protection, fragile states, World Bank, development, state-building
Contextual description:
Research paper examining the integration of the social protection and fragile states agendas within the World Bank, analyzing institutional barriers to their collaboration.
Authors:
Y.D.T.I. Karunarathna; D.S. Wijetunga; R.R.M.K.P. Ranatunga
Affiliation:
Center for Marine Science and Technology, Department of Zoology, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka
Corresponding author:
R.R.M.K.P. Ranatunga
Email:
[email protected]
Country:
Sri Lanka
Region:
Attanagalu River Basin; Negombo Lagoon
River basin extent:
779 km2
River length:
Approximately 76 km
Sampling sites:
15 locations along the river
Sampling period:
May 2019 and October 2019
Seasons:
Southwest monsoon and second inter-monsoon
Type of document:
Scientific research article
Field of study:
Environmental science; freshwater ecology; microplastic pollution
Keywords:
Attanagalu River; freshwater ecosystems; microplastics; sediment; surface water
Methods:
Surface water sampling with plankton net (100 µm mesh); sediment sampling with Van Veen grab sampler; Raman Spectroscopy polymer identification
Polymers identified:
Polypropylene; polyethylene; polystyrene; polyvinyl chloride
Microplastic types detected:
Secondary microplastics; fibers dominant
Water microplastic abundance:
1.12–17.45 items m⁻³
Sediment microplastic abundance:
11.38–129.47 items kg⁻¹
Year:
2026
Region / City:
United States, Utah
Subject:
Electric heating cables for pipe tracing and roof/gutter de-icing
Document Type:
Technical specification
Organization / Institution:
Warmzone
Author:
Warmzone Engineering Department
Target Audience:
Electrical contractors, HVAC and plumbing engineers
Effective Period:
Construction project duration
Approval Date:
Not specified
Revision Date:
Not specified
Standards Compliance:
NFPA 70, UL, IEEE 515, CSA, ETL
Year:
2020
Organization:
U.S. Department of Homeland Security (DHS)
Document Type:
Procedural Script
Audience:
DHS Employees, Contractors, Interns, Volunteers
Purpose:
Guidance for conducting voluntary contact tracing calls
Scope:
Workplace exposure to COVID-19
Privacy Considerations:
Personally identifiable information limited; medical information not collected from contractors, interns, or volunteers
References:
CDC COVID-19 Guidance
Form Used:
COVID-19 Contact Tracing Form
Duration:
Call length varies depending on exposure assessment and responses
Year:
2026
Author:
aogultegin
Type of document:
Educational activity guide
Target audience:
Children
Content focus:
Physical movement and letter recognition
Format:
Text instructions with numbering
Year:
2021
Region / City:
Greenland
Topic:
Glaciology, Noble Gas Analysis
Document Type:
Supplementary Material
Organization:
University of Michigan, Woods Hole Oceanographic Institution
Authors:
Yi Niu, M. Clara Castro, Sarah M. Aciego, Chris M. Hall, Emily I. Stevenson, Carli A. Arendt, Sarah B. Das
Target Audience:
Researchers, Scientists
Period of Validity:
Ongoing
Approval Date:
2021
Modification Date:
None
Note:
Year
Topic:
Vaccination Consent
Document Type:
Consent Form
Target Audience:
Patients, Healthcare Providers
Year:
2025
Region / city:
England
Topic:
Immunization
Document type:
Patient Group Direction (PGD)
Organization / institution:
UK Health Security Agency (UKHSA)
Author:
Suki Hunjunt, Professor Shamez Ladhani, David Green
Target audience:
Healthcare professionals involved in immunization
Period of validity:
From 5 January 2026 to 5 January 2029
Approval date:
5 January 2026
Amendment date:
2 June 2025, 16 December 2025
Description:
A document detailing the administration guidelines for the pneumococcal polysaccharide conjugate vaccine (PCV13, PCV15) for children under 2 years old in the UK.
Year:
2025
Region / City:
London
Topic:
Neonatal BCG vaccination program
Document Type:
Protocol
Organization / Institution:
NHSE
Author:
Alice Waters
Target Audience:
Healthcare professionals involved in neonatal care and immunization
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
September 2025
Year:
2023
Region / City:
N/A
Subject:
Vaccination
Document Type:
Medical Guidelines
Organization / Institution:
Merck
Author:
N/A
Target Audience:
Healthcare professionals
Effective Period:
N/A
Approval Date:
07/13/2015
Revision Dates:
07/13/2015, 11/15/2015, 06/2016, 04/2023, 08/2024
Year:
2025
Region / city:
United Kingdom
Subject:
COVID-19 vaccination
Document type:
Protocol
Institution:
UK Health Security Agency (UKHSA)
Author:
UK Health Security Agency (UKHSA)
Target audience:
Healthcare providers involved in COVID-19 vaccination
Period of validity:
1 October 2025 – 31 January 2026
Approval date:
12 September 2025
Note:
Revision history
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Year:
2025
Region / city:
England
Topic:
Influenza immunisation
Document type:
Patient Group Direction (PGD)
Organisation:
UK Health Security Agency (UKHSA)
Author:
Christina Wilson, Jamie Lopez-Bernal, Greta Hayward
Target audience:
Healthcare practitioners, NHS organisations
Period of validity:
From 1 September 2025 to 1 April 2026
Approval date:
3 July 2025
Revision history:
Updated annually, latest update 9 July 2025
Reference no:
HPV (GBMSM) PGD
Version no:
v5.0
Valid from:
1 September 2025
Review date:
1 April 2028
Expiry date:
1 September 2028
Author:
Suki Hunjunt, Sharif Ismail, David Green
Region / city:
England
Target audience:
Healthcare practitioners administering HPV vaccine to GBMSM
Type of document:
Patient Group Direction
Organisation:
UK Health Security Agency (UKHSA)
Date of approval:
17 July 2025
Date of modifications:
16 July 2025
Context:
A formal Patient Group Direction for the administration of HPV vaccine to GBMSM, detailing legal, clinical, and procedural requirements for healthcare practitioners in England.
Reference no:
Hib/MenC PGD
Version no:
v6.0
Valid from:
1 July 2025
Expiry date:
30 April 2026
Authorising organisations:
UK Health Security Agency (UKHSA)
Target audience:
Registered healthcare practitioners
Responsible body:
UKHSA
Note:
Amendment history
v1.0 and v2.0:
See previous versions of this PGD template for details (19 January 2016 to 23 April 2018)
v3.0:
PHE Hib/MenC PGD amended to: include vaccination of individuals for the prevention of secondary cases of meningococcal group C disease (24 April 2018)
v4.0:
PHE Hib/MenC PGD amended to: remove reference to individuals with an underlying medical condition (5 March 2020)
v5.0:
UKHSA Hib/MenC PGD amended to: include minor rewording of standard text, layout and formatting changes (4 May 2022)
v6.0:
UKHSA Hib/MenC PGD amended to: include minor rewording, updated references, and changes to the childhood immunisation schedule (2 June 2025)
Developed by:
Christina Wilson (Lead Pharmacist), Professor Shamez Ladhani (Paediatric Infectious Diseases Consultant), David Green (Nurse Consultant for Immunisation Programmes)
Peer-reviewed by:
UKHSA Immunisations PGD Expert Panel
Date approved:
2 June 2025
Year:
2025
Region / city:
Global
Topic:
Vaccine Policy, Maternal Health, Group B Streptococcus
Document type:
WHO Guidance
Institution:
World Health Organization (WHO)
Author:
WHO ECVP
Target audience:
Policymakers, Vaccine Developers, Public Health Authorities
Period of validity:
Ongoing
Approval date:
March 11, 2025
Date of changes:
Not specified
Year:
2025
Region:
England
Subject:
Hepatitis B vaccination for renal patients
Document Type:
Patient Group Direction (PGD)
Authorising Organisation:
UK Health Security Agency (UKHSA)
Target Audience:
Registered healthcare professionals
Period of Validity:
28 February 2025 - 28 February 2028
Approval Date:
28 February 2025
Amendment Date:
21 February 2025